期刊文献+

Liver Stiffness Measurement Can Reflect the Active Liver Necroinflammation in Population with Chronic Liver Disease:A Real-world Evidence Study 被引量:8

原文传递
导出
摘要 Background and Aims: Non-invasive evaluation of liver nec-roinflammation in patients with chronic liver disease is an un-met need in clinical practice.The diagnostic accuracy of transient elastography-based liver stiffness measurement(LSM)for liver fibrosis could be affected by liver necroinflam-mation,the latter of which could intensify stiffness of the liver.Such results have prompted us to explore the diagnosis potential of LSM for liver inflammation.Methods: Three cross-sectional cohorts of liver biopsy-proven chronic liver dis-ease patients were enrolled,including 1417 chronic hepatitis B(CHB)patients from 10 different medical centers,106 non-al-coholic steatohepatitis patients,and 143 patients with auto-immune-related liver diseases.Another longitudinal cohort of 14 entecavir treatment patients was also included.The re-ceiver operating characteristic(ROC)curve was employed to explore the diagnostic value of LSM.Results: In CHB patients,LSM value ascended with the increased severity of liver nec-roinflammation in patients with the same fibrosis stage.Such positive correlation between LSM and liver necroinflammation was also found in non-alcoholic steatohepatitis and autoim-mune-related liver diseases populations.Furthermore,the ROC curve exhibited that LSM could identify moderate and se-vere inflammation in CHB patients(area under the ROC curve as 0.779 and 0.838)and in non-alcoholic steatohepatitis pa-tients(area under the ROC curve as 0.826 and 0.871),respec-tively.Such moderate diagnostic value was also found in autoimmune-related liver diseases patients.In addition,in the longitudinal entecavir treated CHB cohort,a decline of LSM values was observed in parallel with the control of inflam-matory activity in liver.Conclusions: Our study implicates a diagnostic potential of LSM to evaluate the severity of liver necroinflammation in chronic liver disease patients.
出处 《Journal of Clinical and Translational Hepatology》 SCIE 2019年第4期313-321,共9页 临床与转化肝病杂志(英文版)
基金 the National S&T Major Project for Infectious Diseases(2017ZX10201201,2017ZX10202202,2017ZX10302201 and 2017ZX10202203) the project from Beijing Municipal Science & Technology Commission(Z161100000116047) Project funded by China Postdoc-toral Science Foundation(2017M620544,2018T110014) Project funded by Shenzhen Municipal Health Commission(SZSM201612071)
  • 相关文献

参考文献2

二级参考文献10

  • 1Albert J. Czaja.Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis[J]. Current Pharmaceutical Design . 2011 (29)
  • 2Sara Lemoinne,Axelle Cadoret,Haquima El Mourabit,Dominique Thabut,Chantal Housset.Origins and functions of liver myofibroblasts[J].BBA - Molecular Basis of Disease.2013(7)
  • 3Edith Hintermann,Janine Ehser,Monika Bayer,Josef M. Pfeilschifter,Urs Christen.Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6[J].Journal of Autoimmunity.2013
  • 4Hajime Tanaka,Patrick S. C. Leung,Tom P. Kenny,M. Eric Gershwin,Christopher L. Bowlus.Immunological Orchestration of Liver Fibrosis[J].Clinical Reviews in Allergy & Immunology.2012(3)
  • 5Juliane S. Troeger,Ingmar Mederacke,Geum–Youn Gwak,Dianne H. Dapito,Xueru Mu,Christine C. Hsu,Jean–Philippe Pradere,Richard A. Friedman,Robert F. Schwabe.Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice[J].Gastroenterology.2012(4)
  • 6Scott Laurence Friedman.Fibrogenic cell reversion underlies fibrosis regression in liver[J].Proceedings of the National Academy of Sciences.2012(24)
  • 7Tatiana Kisseleva,Min Cong,YongHan Paik,David Scholten,Chunyan Jiang,Chris Benner,Keiko Iwaisako,Thomas Moore-Morris,Brian Scott,Hidekazu Tsukamoto,Sylvia M. Evans,Wolfgang Dillmann,Christopher K. Glass,David A. Brenner.Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis[J].Proceedings of the National Academy of Sciences.2012(24)
  • 8Virginia Hernández–Gea,Zahra Ghiassi–Nejad,Raphael Rozenfeld,Ronald Gordon,Maria Isabel Fiel,Zhenyu Yue,Mark J. Czaja,Scott L. Friedman.Autophagy Releases Lipid That Promotes Fibrogenesis by Activated Hepatic Stellate Cells in Mice and in Human Tissues[J].Gastroenterology.2012(4)
  • 9Ursula E. Lee,Scott L. Friedman.Mechanisms of hepatic fibrogenesis[J].Best Practice & Research Clinical Gastroenterology.2011(2)
  • 10Anna S. Lok,James E. Everhart,Elizabeth C. Wright,Adrian M. Di Bisceglie,Hae–Young Kim,Richard K. Sterling,Gregory T. Everson,Karen L. Lindsay,William M. Lee,Herbert L. Bonkovsky,Jules L. Dienstag,Marc G. Ghany,Chihiro Morishima,Timothy R. Morgan.Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C[J].Gastroenterology.2011(3)

共引文献112

同被引文献90

引证文献8

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部